Congenital Ichthyosis Subtype Analysis of Primary Efficacy of a Novel Topical Isotretinoin Formulation (TMB-001): Results from the Phase 2b CONTROL study in Patients with Recessive X-Linked and Autosomal Recessive Lamellar Congenital Lchthyosis
Authors: Dedee F. Murrell, Joyce Teng, Scott Guenthner,Kalyani Marathe, Steven Kempers, Kimmie Eads,Leslie Castelo-Soccio, Alan M. Mendelsohn, Jessica Raiz, Christopher G. Bunick
< PREVIOUS POSTER NEXT POSTER >
